Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Cambridge, Massachusetts
- Most recent report
- 10-Q, filed Nov 5, 2026
- Incorporated
- Delaware
- Filings on record
- 443 filings
- On EDGAR
- CIK 1658551
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer, Smaller reporting company
Financials 8 of 20
News 8 of 56
Prospectuses and Registrations 8 of 21
- 424B5 Prospectus supplement for an offering Aug 20, 2026
- 424B5 Prospectus supplement for an offering Aug 18, 2026
- S-8 Registration statement for an employee plan Mar 3, 2026
- S-3ASR Automatic shelf registration Mar 3, 2026
- 424B5 Prospectus supplement for an offering Sep 10, 2025
- 424B5 Prospectus supplement for an offering Sep 9, 2025
- S-8 Registration statement for an employee plan Mar 4, 2025
- S-3 Shelf registration statement Mar 4, 2025
Proxies 8 of 10
- DEFA14A Extra proxy material Apr 23, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 23, 2026
- DEFA14A Extra proxy material Apr 24, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 24, 2025
- DEFA14A Extra proxy material Apr 24, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 24, 2024
- DEFA14A Extra proxy material Apr 27, 2023
- DEF 14A Proxy statement for a shareholder vote Apr 27, 2023
Ownership 8 of 292
- 144 Notice of a proposed sale of restricted stock Nov 9, 2026
- 144 Notice of a proposed sale of restricted stock Nov 9, 2026
- 144 Notice of a proposed sale of restricted stock Nov 9, 2026
- 4 Insider reported a trade Oct 7, 2026
- 144 Notice of a proposed sale of restricted stock Oct 5, 2026
- 4 Insider reported a trade Sep 14, 2026
- 4 Insider reported a trade Sep 14, 2026
- 4 Insider reported a trade Sep 14, 2026
Other 8 of 44
- ARS Annual report sent to shareholders Apr 23, 2026
- ARS Annual report sent to shareholders Apr 24, 2025
- EFFECT Notice that a registration became effective Mar 26, 2025
- CORRESP Reply to SEC staff Mar 24, 2025
- UPLOAD Comment letter from SEC staff Mar 5, 2025
- POSASR Mar 4, 2025
- ARS Annual report sent to shareholders Apr 24, 2024
- UPLOAD Comment letter from SEC staff Dec 20, 2023
Everything here comes from Amylyx Pharmaceuticals, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.